|
|
||||||||
1 From the Departments of Physiology and 2 Medicine, Division of Rheumatology, The University of Tennessee Health Science Center, Memphis, Tennessee.
| Abstract |
|---|
|
|
|---|
METHODS. IClLPA and resting voltages were recorded with the amphotericin perforated-patch technique. Phenotype was determined with antibodies to
-smooth muscle actin.
RESULTS. Keratocytes cultured in serum have a phenotype (myofibroblast) and ionic currents similar to those of keratocytes isolated directly from corneas during wound healing. LPA and S1P both activated IClLPA in a dose-dependent manner, and the LPA receptorspecific antagonist dioctyl-glycerol pyrophosphate (DGPP) blocked the LPA response, but not the S1P response. In addition, a relatively inactive form of LPA (LPA 8:0) was relatively ineffective in activating IClLPA. Activation of IClLPA significantly depolarized the cells, and this depolarization was reversed by blocking IClLPA with 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) or 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB).
CONCLUSIONS. These results demonstrate that activation of IClLPA by LPA in cultured corneal keratocytes is receptor mediated and that IClLPA can also be activated by S1P. From a functional standpoint, this work confirms that the current, which is typically thought of as purely volume-activated, can be activated through a receptor. In addition, activation of IClLPA results in depolarization of the keratocyte. Finally, this work demonstrates that cultured corneal keratocytes can act as a model for the study of ion channel function in keratocytes during corneal wound healing.
| Introduction |
|---|
|
|
|---|
In the corneal stroma, keratocytes are responsible for the bulk of the corneal wound-healing response. Corneal keratocytes reside between the collagen lamellae of the stroma, normally in a quiescent state. Approximately 10% of the dry weight of the cornea is composed of keratocytes, of which there are an estimated 2.43 million per human cornea.1 2 After injury, keratocytes activate and migrate to the wound site, where they proliferate and initiate a host of wound-healing activities related to matrix degradation and repair. During wound healing, corneal keratocytes lose the prominent whole-cell ionic currents typically found in quiescent cells: a K+-selective outwardly rectifying current and a voltage-sensitive, tetrodotoxin (TTX)-inhibitable Na+ current.3 These activated, migrating cells also become responsive to serum and lysophosphatidic acid (LPA) by activating a Cl- current (IClLPA) that is also activated during cellular swelling.4 This is significant, in that IClLPA is rarely seen in keratocytes isolated from uninjured corneas.
IClLPA activation is significant, in that LPA, along with several other LPA-like phospholipid growth factors (PLGFs) including cyclic LPA, alkenyl-LPA, lysophosphatidylserine, and phosphatidic acid, are present in the aqueous humor and/or the lacrimal fluid.5 In a previous study, we found that corneal wounding resulted in a physiologically significant increase in the concentration of these lipids. In this same study, it was shown that LPA, alkenyl-LPA, and lipopolysaccharide LPS all significantly increased cell mitosis in acutely isolated rabbit corneal keratocytes. In other cell types, the biological activities of LPA and PLGFs include mitogenic or antimitogenic effects, regulation of Ca2+ homeostasis, regulation of the actin cytoskeleton, and inhibition of apoptosis.6 7
To date, there have been nine receptors cloned that are specifically activated by the recently recognized class of PLGFs. These receptors belong to two distinct gene families, including one in the PSP24 family and eight in the LPA-sphingosine-1-phosphate (S1P) family.6
8
9
PSP24 and LPA1-3 all bind LPA, whereas S1P1-5 most avidly bind S1P. All the PLGF receptors studied to date have been linked to a G-protein signaling cascade. LPA1 has been linked to G
i,10
11
LPA2 appears to be linked to both G
i and G
q,11
12
and LPA3 appears to be linked only to G
q.13
We have published functional evidence that the LPA-activated response in acutely isolated wound-activated keratocytes (WAKs) is receptor mediated.4
7
The evidence from these studies indicates that the receptors mediating IClLPA responses in WAKs are activated by both alkenyl-GP and LPA, but not by lysophosphatidyl choline. All these previous rabbit keratocyte electrophysiology studies were performed in acutely isolated cells, whereas the functional studies were performed in cultured cells. The present study was designed in part to determine whether, indeed, cultured rabbit corneal keratocytes also contain IClLPA. Because many cell types change their ion channel profiles once placed in culture, this is an important question. If cultured keratocytes contain IClLPA, these cells can serve as a model to examine the transduction pathways underlying the receptor-mediated response, as well as the functional significance of IClLPA activation in WAKs. This is significant, in that with the exception of its activation in keratocytes, this current is typically found to be activated by increases in cell volume and not through a receptor-mediated pathway.4
7
This study was also designed to determine whether cultured keratocytes have minimal K+ and Na+ current expression, as seen in WAKs. Finally, the study was designed to determine the effect of activation of IClLPA on the resting voltage (Em) of these cells and to examine the possibility that S1P also activates IClLPA.
| Methods |
|---|
|
|
|---|
To determine the phenotype of the cells we were using for the patch-clamp studies, the method described by Masur et al.15
was used. Briefly, cells grown in our standard culture conditions were subjected to immunohistochemical analysis with an FITC-labeled antibody against
-smooth muscle actin (
SMA; Sigma, St. Louis, MO). Cells were plated at low density (103 cells/mL) and analyzed 2 to 3 days after passage and at high density (105 cells/mL) and analyzed 3 to 4 days after passage. At the specified time, cells were harvested and fixed (Histochoice; Amresco, Solon, OH) for 15 minutes, permeabilized with Triton-X-100, blocked with 2% BSA, and incubated with the FITC-labeled antibody. Control cells were treated in the same manner, with no antibody incubation.
Electrophysiology
Cells were patch clamped using the amphotericin whole-cell perforated-patch technique.16
Briefly, currents were recorded using a patch-clamp amplifier (model 200A; Axon Instruments, Burlingame, CA) and accompanying software (pClamp 8.0; Axon Instruments). Records were capacity compensated by the amplifier circuitry, sampled at 2 kHz, and filtered at 1 kHz. Cell capacitance was recorded for current density calculations (shown later). The pipette solution contained (in mM) 145 KOH, 100 methanesulfonic acid (MeS), 2.5 NaCl, 2.5 CaCl2, 5 HEPES, and 240 mg/mL amphotericin B (Sigma). Unless otherwise noted, the bathing solution contained (in mM) 145 NaCl, 5 KCl (145 KCl, 2.5 NaCl for the KCl bath), 2.5 CaCl2, 5 glucose, and 5 HEPES. To determine the permeability of IClLPA to MeS, an NaMeS-Cl bath solution containing (in mM) 65 NaCl, 65 NaMeS, 2.5 KCl, 1 CaCl2, and 5 HEPES was used. Electrodes were coated (Sylgard; Dow Corning, Midland, MI) and fire polished.
Em was measured by noting the reversal potential (Erev) from current-voltage (I-V) relationships. In instances in which currents were too small to reliably measure Erev, or no current was active until the more depolarized voltage pulses, cells were current clamped to 0 pA, and Em was read directly off of the patch-clamp amplifier digital display. Voltages were corrected for junction potentials by -15.4 mV, as estimated using the junction potential calculator included in the software package. The mobility of KMeS was set at 0.66 (Barry P, personal communication, 2002). In all cases, Em comparisons were made before and after addition of agonists (and in some cases blockers) within the same cell (i.e., paired comparisons).
IClLPA activation was examined under several conditions. In one series of experiments, different concentrations of LPA (100 nM10 µM) were added to the bath to determine whether there was a dose-dependent effect of LPA on peak IClLPA current density (peak current/cell capacitance). In a second series of experiments, different concentrations of S1P (100 nM10 µM) were added to the bath to determine whether S1P activates IClLPA and whether there was a dose-dependent effect of S1P on peak IClLPA current density. We also exposed the cells to a hyposmotic solution (220 mOsm) to confirm that the cultured cells contain the volume-activated Cl- current seen in acutely isolated cells. Finally, permeability of MeS through IClLPA was determined by using the bath solution described earlier and a tail current protocol to measure Erev. Cells were treated with 10 µM LPA, clamped according to an activation protocol (as in Fig. 2A ) to ensure that IClLPA was active, and then clamped with the tail-current protocol. For this protocol, cells were held at 0 mV, depolarized to 85 mV, and hyperpolarized to a series of voltages from 65 to -115 mV, in 15-mV intervals. The Cl:MeS permeability ratio was calculated with the Erev measured when the cells were bathed in the NaCl and NaMeS-Cl baths, respectively, and with the Goldman-Hodgkin-Katz equation.17
|
Chemicals
Unless otherwise stated, chemicals were obtained from Sigma. LPA (8:0 and 18:1), S1P, and DGPP were purchased from Avanti Polar Lipids (Alabaster, AL).
Statistics
A paired Students t-test was used to compare results for all Em studies. Analysis of variance (ANOVA) with least-squares means was used to compare the effects of different doses of LPA and S1P on the current density response.
| Results |
|---|
|
|
|---|
SMA. Figure 1A
shows positive
SMA staining in our standard cells (low density) used for the electrophysiological studies. Figure 1B
shows relatively negative staining in high-density cells. Figure 1C
shows the negative control (no antibody).
|
LPA-Activated Current
IClLPA was observed in most cells treated with 100 nM or more LPA (Figs. 3A
3B)
. Average time to current activation after LPA exposure was approximately 5.6 minutes. This is similar to our finding in acutely isolated WAKs,4
whereas the volume-activated current was active as soon as we began the protocol after a solution change in both cultured and isolated cells (within 15 seconds). As in cells acutely isolated from WAKs, the current began to inactivate at depolarized voltages and was blocked by 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB; 50 µM; Fig. 3C
) and 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS; 100 µM: data not shown). Figure 3D
shows the I-V relationship for the currents shown in Figures 3A
3B
and 3C
. IClLPA was activated in all cell types examined, whether or not they expressed the delayed rectifying K+ current. Figure 3E shows tail current I-V curves from a representative cell bathed in NaCl Ringers and in the MeS-Cl bath. As can be seen, Erev in the NaCl and MeS-Cl solutions was -21 mV and -16 mV, respectively. If the current were carried by both Cl and MeS, the expected Nernst potentials would be -10 mV in the NaCl bath and -7 mV in the MeS-Cl bath. If the current were not carried by MeS, the expected Nernst potentials would be -107 mV and -86 mV in the NaCl and MeS-Cl bathing solutions, respectively. The mean (± SD) Cl-MeS permeability ratio equaled 1.22 ± 0.26 (n = 5). Thus, the channel is almost as permeable to MeS as to Cl-.
|
0.001). All concentrations of LPA were also significantly different from those in the the 1-µM and 10-µM groups (P
0.001). In the DGPP experiments (Fig. 5)
, 10 µM DGPP prevented IClLPA activation so that the current density of this group was significantly lower than the LPA control (1 µM; P = 0.001) and not different from the untreated control. Neither the lowest concentration of DGPP (1 µM) nor the methanol control significantly blocked the LPA-activated current. The volume-activated Cl- current was not affected by DGPP (10 µM; n = 7; data not shown).
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
It has been shown that keratocytes grown in serum at low density become
SMA positive and thus are classified as myofibroblasts, which is the phenotype of keratocytes found in wound-healing conditions.15
In contrast, cells grown under similar conditions at high density remain
SMA negative. In the presence of serum, these cells are typically of the fibroblast phenotype.19
These high-density cells could be converted to
SMA positive in the presence of TGF-ß. To establish and confirm the phenotype of the keratocytes used in the present study, immunohistochemistry was performed on cells cultured at low density (the cells we typically used for patch-clamp experiments) and at high density. These studies demonstrated that the cultured keratocytes we routinely use in the electrophysiological studies are
SMA positive, indicating that immunohistochemically they can be classified as cells of the myofibroblast phenotype. Because of the relative absence of K+ or Na+ currents and the ability of LPA to activate IClLPA in these cultured keratocytes, they can also functionally be classified as cells of the wound-healing phenotype.3
Maltseva et al.20
have recently demonstrated that myofibroblasts can be reverted to the
SMA-negative phenotype. It will be interesting to see whether these reverted cells regain the K+ and Na+ currents lost in the initial transition to the myofibroblast phenotype.
Previous studies examining the influence of LPA on WAK ion channels provided an initial characterization of the biophysical properties of IClLPA. They also provided some functional evidence that IClLPA is activated by LPA through a receptor-mediated response, as opposed to a cell volumemediated response.4 7 This evidence includes a dose-dependence study of LPA on peak amplitude of IClLPA current, failure of lysophosphatidyl choline (LPC) to activate IClLPA, and absence of activation of the current by LPA in a cell in which the current could be activated by an acute increase in volume. This last experiment demonstrated that the cell being examined was capable of expressing the Cl- current, but in that instance, not through activation of the LPA receptor. The present study demonstrates that the dose-dependent effect of LPA on peak density of IClLPA current is also present in cultured keratocytes (Fig. 4) . The results demonstrating that the relatively inactive short-chain LPA (8:0) was significantly less effective at activating IClLPA than LPA (18:1) provide new evidence that LPA activates IClLPA through a receptor-mediated pathway. Because short-chain LPA is a much closer analogue to LPA than LPC, it serves as a more appropriate negative control for this type of study. That 10 µM short-chain LPA was not significantly different from the 100- or 300-nM LPA (18:1) groups in activating IClLPA indicates that the short-chain LPA either has a very weak affinity for LPA receptors or that it can possibly activate IClLPA through a yet to be described receptor or pathway.
Additional evidence for receptor-mediated activation of IClLPA was provided by the experiments demonstrating inhibition of LPA activation of the current by the LPA receptor antagonist DGPP. In contrast, S1P activation of IClLPA was not inhibited by DGPP. Given that 1 µM DGPP was relatively ineffective at blocking IClLPA, whereas 10 µM was significantly effective, it appears that IClLPA activation is mediated through the LPA1 receptor (DGPP blocks LPA1 with a Ki of 6.6 µM versus LPA3 with a Ki of 106 nM).18 This must be confirmed in more detailed studies.
LPA is known to be a strong activator of Rho.21
Nilius et al.22
provided strong evidence that the Rho-Rho kinase pathway is involved in the volume-regulated anion channel activation cascade in bovine vascular endothelial cells; thus, it is possible that LPA is acting through this pathway to activate IClLPA in WAKs. Postma et al.23
determined that LPA activation of an anion channel distinct from the volume-activated channel occurs through a G
13 mediated, Rho-independent pathway. It should be noted that activation of this Cl- channel also depolarizes the cells. At this time, it is not possible to state which, if either, of these pathways is involved in LPA activation of IClLPA.
To date, no function has been attributed to activation of IClLPA in corneal keratocytes. Because the LPA concentration surrounding and presumably within the cornea becomes elevated after corneal wounding,5 it seems likely that there is significant IClLPA activity associated with this increased LPA concentration. This study clearly demonstrates that IClLPA activation results in cell depolarization and that block of IClLPA repolarizes the cell. Because this is the first study to measure Em in any keratocyte model, it is not clear what the physiological consequences of the depolarization might be. It would be expected that the loss of the delayed rectifying K+ current in WAKs would lead to some degree of cell depolarization.3 In our study IClLPA activation further depolarized the cells. Of course, significant depolarization alters the steady state ion concentrations and transport properties of the cell. This depolarization may be required for some of the activities performed by keratocytes during wound healing. In addition to the effects of depolarization on ion concentrations and transport, many studies have demonstrated that cell depolarization enhances the transcription of a number of different proteins.24 25 26 27 28 This transcription response is typically (although not always) mediated by a depolarization-induced increase in intracellular Ca2+ concentration. Although there are no reports of depolarization-induced increases in keratocyte intracellular Ca2+ concentration, this possibility cannot be ruled out. Depolarization has also been shown to inhibit polyamine transport into ZR-75-1 human breast cancer cells.29 Polyamines have been shown to be critical for cell migration and mitosis and are involved in DNA transcription.30 31 We have previously reported that disruption of polyamine synthesis in corneal cells, including keratocytes, inhibits proliferation.32 Depolarization-induced inhibition of keratocyte polyamine transport could act to control keratocyte proliferation and migration during wound healing.
This study also demonstrates that IClLPA is permeable to the relatively large anion, MeS. In many cell types, movement of large anions through volume-activated anion channels serves both a metabolic function and a regulatory function to decrease volume. These responses have yet to be studied in keratocytes.
In conclusion, this work demonstrates that cultured corneal keratocytes can act as a useful model for the study of ion channel function in the WAK phenotype. As in keratocytes acutely isolated from wounded corneas, these cultured cells have little or no K+ or Na+ currents (the primary conductances in quiescent keratocytes), and they contain IClLPA (rarely seen in quiescent cells). This study provides detailed evidence that activation of IClLPA by LPA is receptor mediated and that IClLPA can also be activated by S1P. Finally, this study demonstrates that activation of IClLPA significantly depolarizes the cell.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication February 21, 2002; revised May 23, 2002; accepted June 3, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Mitchell A. Watsky, Department of Physiology, The University of Tennessee Health Science Center, 894 Union Avenue, Memphis, TN 38163; mwatsky{at}physio1.utmem.edu.
| References |
|---|
|
|
|---|
(13) mediates activation of a depolarizing chloride current that accompanies RhoA activation in both neuronal and nonneuronal cells Curr Biol 11,121-124[Medline][Order article via Infotrieve]
1 and
5 GABAA receptor subunits Brains Res Mol Brain Res 28,338-342
This article has been cited by other articles:
![]() |
Z. Yin, Y. Tong, H. Zhu, and M. A. Watsky ClC-3 is required for LPA-activated Cl- current activity and fibroblast-to-myofibroblast differentiation Am J Physiol Cell Physiol, February 1, 2008; 294(2): C535 - C542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, Z. Liu, and K. E. Meier Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1089 - C1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Kim, G. H. Liang, J. A. Kim, Y. J. Kim, S. Oh, and S. H. Suh Sphingosine-1-phosphate activates BKCa channels independently of G protein-coupled receptor in human endothelial cells Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1000 - C1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yin and M. A. Watsky LPA and S1P Increase Corneal Epithelial and Endothelial Cell Transcellular Resistance Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 1927 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Danieli-Betto, E. Germinario, A. Esposito, A. Megighian, M. Midrio, B. Ravara, E. Damiani, L. D. Libera, R. A. Sabbadini, and R. Betto Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1367 - C1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yin and M. A. Watsky Chloride channel activity in human lung fibroblasts and myofibroblasts Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1110 - L1116. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |